Ledger.Open graph →
SEC Form D · filed November 21, 2018

Keros Therapeutics, Inc

Offering
$23.0M
Sold
$11.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
LEXINGTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (17)

Alon S. Lazarus · Lexington, MADirectorOhad S. Hammer · Lexington, MADirectorRan S. Nussbaum · Lexington, MADirectorJasbir S. Seehra · Lexington, MAExec · DirectorJulius S. Knowles · Lexington, MADirectorZafrira S. Avnur · Lexington, MADirectorPatricia W. Seminario · Portland, ORDirectorFrancisco J. Gonzalez · Miami, FLDirectorJuan J. De Abreu Macedo · Miami, FLExec · DirectorGeoffrey O. Kalish · New York, NYDirectorDaniel M. Freeman · London, United KingdomDirectorEmil W. Henry, Jr · New York, NYDirectorAlessandro M. Boninsegna · New York, NYDirectorRichard J. Trabulsi · New York, NYDirectorKevin M. Morse · Merrillville, INExec · DirectorDean Hatton · Fort Lauderdale, FLDirectorZafrira S. Avnur · Lexington, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗